None listed
Conditions
Brief summary
Normal ageing is associated with a marked structural and functional reduction in the cerebrovascular system, which is linked to cognitive decline and dementia. Given the rapid increase in ageing and life expectancy, and the related medical costs associated with treatment of age-related disorders, identifying effective interventions to stop or delay the normal decline in cerebrovascular function are critical. Research has demonstrated that regular aerobic endurance exercise is associated with improved health of blood vessels in the brain in men aged 18-79 years, potentially also improving cognition and mood. This finding in endurance trained men may therefore help explain why there is a lower risk of cerebrovascular disease in this population. However, this research was undertaken in a small sample of male older adults and the function of the blood vessels in the brain to cognitive and chemical stimuli was not evaluated. Accordingly, we will investigate cerebrovascular function, mood and cognition in aerobic endurance trained and untrained middle-aged and older (50-80 years) adults. The significance of this project is that it may be the first research study to demonstrate that regular aerobic endurance training is associated with improved brain blood vessel health, cognitive function and mood in a population that is at risk of cerebrovascular disease, which is linked to cognitive decline and dementia.
Interventions
We will aim to recruit one hundred and thirty-five participants for this study. Recruitment will occur via an approved media release that incorporates physical advertisement, social media and information on the USQ website. The individuals will be recruited from community organisations in and around Ipswich, Toowoomba and Brisbane. Respondents will initially be screened for suitability using the Lifetime Physical Activity Questionnaire (LPAQ), Exercise and Sports Science Australia (ESSA) Adult Pre-exercise Screening System, the Yale Physical Activity Survey and a medical history questionnaire to determine whether participants meet the inclusion and/or exclusion criteria. Once participants are recruited, voluntary written informed consent will be obtained prior to any assessment being performed. Further, participants will be asked to complete a nutritional questionnaire, so that this can be assessed and that any effects that are noted throughout the study are due to exercise and not just due to changes in nutritional behaviour. The two arms of this study will consist of the untrained adults who do not participate in any exercise training, and a second arm will consist of the aerobic exercise trained adults, as determined by the aforementioned surveys. Once informed about the study and its requirements, by providing potential participants with a participant information sheet, participants that meet part of the inclusion criteria will attend USQ Ipswich for baseline screening and testing. The first screening visit will take approximately 2-2.5hrs and the second visit will take approximately 30-40min. These visits will occur on consecutive days. Prior to the start of any testing during visit 1, informed consent will be first voluntarily obtained and, once acknowledged, testing and screening will commence. These visits will incorporate the following methods: • Cerebrovascular responsiveness to hypercapnia and cognitive stimuli (NIH Toolbox, Trail Making Task) using transcranial Doppler sonography; • Profile of Mood States to ascertain current mood; • Anthropometry, determined by body weight and height (body mass index calculation), waist and hip circumferences (waist to hip ratio calculation) and Dual-energy X-ray absorptiometry (DEXA) which will ascertain body composition of total fat mass, lean mass, body fat percentage, and bone mineral content and density; • Systolic and diastolic blood pressure and arterial elasticity will be measured non-invasively using a Research Cardiovascular Profiling System; • Biomarker analyses after blood is collected; and • Exercise capacity will be assessed using a 6 minute walk test and handgrip strength will be determined using hand dynamometry.
Sponsors
Eligibility
Inclusion criteria
Be aged 50-80 years Be physically inactive (Control - (<150 minutes physical activity per week) Be physical active and aerobic exercise trained (Arm 2 - >150 minutes physical activity per week and a high score on the Lifetime Physical Activity Questionnaire). Have blood pressure below 160/100mmHg (we will determine this at the screening visit) Have an adequate ultrasound signal (we will determine this at the screening visit). Not have heart, kidney or liver disease (excluding fatty liver disease), cancer or a neurological disorder (e.g. stroke) Not taking insulin, anticoagulants or hormone replacement therapy
Exclusion criteria
Cognitive impairment and/or dementia Resting blood pressure greater than 160/100mmHg Chronic kidney disease Chronic liver disease (excluding fatty liver disease) Coronary heart disease Congestive heart failure Atrial fibrillation Prior myocardial infarction Carcinoma (unless in remission or similar) Stroke Aneurysm Epilepsy Multiple sclerosis Parkinson’s disease Neuropathies Presence of a fistulae Smoker Prescribed insulin, hormone-replacement therapy, oral anticoagulants Middle cerebral artery signal absent on Doppler ultrasound